Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.USPTO grants NOA to Amarin Vascepa capsules
The NOA, which is issued based on patent application13/610,217, includes claims for using icosapent ethyl, or EPA, including Vascepa, in lowering triglycerides through the daily administration of about
The NOA, which is issued based on patent application13/610,217, includes claims for using icosapent ethyl, or EPA, including Vascepa, in lowering triglycerides through the daily administration of about
The randomized trial did not meet its primary endpoint of progression-free survival (PFS). According to the analysis of patients enrolled, median PFS was 8.3 months in the experimental
Licence extension includes the use of Zytiga as a combination therapy along with prednisone or prednisolone to treat metastatic castration-resistant prostate cancer (mCRPC), in men who are asymptomatic
Featuring vanilla and strawberry flavours, Souvenaid product is a 125ml once-a-day drink, which includes a combination of nutrients that are naturally present in food. People living with Alzheimer’s
According to the deal, BPC will provide manufacturing services and license proprietary fractionation and purification manufacturing process for Respiratory Syncytial Virus (RSV) intravenous immune globulin to ADMA. BPC
The novel inhibitor of the enzyme glutathione S-transferase P1 1,Telintra activates Jun kinase, which regulates cellular growth and differentiation of blood precursor cells. Telintra investigational agent is being
The company can perform bronchoalveolar lavage (BAL) using study participants from its database. The bronchoscopy suite enables Celerion to discover the expression and quantification of protein biomarkers within
The advancement of the compound into the pre-clinical development triggers an agreed milestone payment to Evotec, under the collaboration signed in March 2008. Evotec chief operating officer Dr
The company anticipates launching both the brands into mass market retailers in the first quarter of 2013. Inergetics CMO Jim Kras said, "The incorporation of our brands allows
The study is designed to assess the safety and immunogenicity of the company’s vaccine in HIV-positive patients who can control infections using oral HIV drug medication. GeoVax president